-
Stakeholder And Contact Window
ESG
Lumosa's Administrative Division is responsible for corporate social responsibility plans and regularly reports to the board of directors. A code of practice for corporate social responsibility has been formulated, and corporate social responsibility related training is regularly promoted at inter-departmental meetings. In order to actively care about climate change issues and fulfill its corporate social responsibility, Lumosa actively implements power saving and waste reduction policies in the course of operations to reduce the impact of company operations on climate change.
- ESG Promotion
- Integrity Management
- Corporate Sustainability
- Risk Management
- Environmental Issues
Lumosa Therapeutics: Our Commitment to ESG
Lumosa firmly believes that corporate responsibility extends far beyond its core business of developing solutions for patients in urgent need of neurological and oncological treatments. We are committed to implementing Environmental, Social, and Governance (ESG) principles and integrating them into our business strategy planning and corporate vision.
Environmental Management
While developing new drugs to address unmet medical needs, we remain vigilant about our environmental footprint. We strive to reduce resource consumption and conserve electricity, promoting material reuse and recycling throughout our operations. Our commitment to environmental management demonstrates our determination to pursue sustainable business practices.
Social Responsibility
Our commitment to social responsibility is embodied in our corporate spirit of "Caring for Life, Selfless Dedication." While we currently do not participate in specific charitable activities, our core mission is to address unmet medical needs—aligning with important social objectives aimed at improving the quality of life for patients globally.
Corporate Governance
Lumosa complies with Taiwan's corporate governance regulations, ensuring transaction transparency and ethical conduct. We strengthen fairness through internal control measures and by promoting prevention of insider trading. We are dedicated to supporting shareholder communication, board oversight, and compliance with legal and regulatory requirements, having appointed a corporate governance officer on May 2023.
To address sustainable development across Environmental, Social, and Governance (ESG) dimensions, our Sustainability Implementation Task Force has established specialized working groups. Responsible departments collect stakeholder concerns regarding environmental protection, occupational safety, supply chain management, labor rights, operational performance, and corporate governance issues, proposing corresponding policies when necessary. To respect stakeholder interests, we have established a dedicated stakeholder section on our company website to appropriately respond to significant sustainability issues of concern.
Lumosa reports ESG implementation results to the Board of Directors at least once annually, deepening board management and participation in the Company's ESG initiatives. Beginning in 2025, we plan to report to the Board on sustainability-related issues, including greenhouse gas inventory, sustainable risk management effectiveness, information security operations, stakeholder communication effectiveness, and corporate governance status.
ESG Outlook
The ESG journey is a process of continuous review and improvement. We are committed to practicing sustainable operations, which not only benefits corporate growth but also creates positive impacts for stakeholders, including investors, business partners, and employees. We sincerely invite you to join this journey and witness how we integrate ESG principles into our corporate culture, demonstrating our firm commitment to caring for life, selfless dedication, and sustainable operations.
Human Rights Policy and Concrete Management Plan
The Company has established human rights policy guidelines based on the Universal Declaration of Human Rights, the UN Guiding Principles on Business and Human Rights, the International Labour Organization standards, and applicable regulations to protect worker rights. Lumosa requires business partners to comply with these standards and local government laws, prohibiting any harm to worker rights and forbidding the use of child labor or worker exploitation.
To ensure compliance, Lumosa follows labor and human rights laws at all operational locations. The company educates new hires and existing employees on human rights protections and worker rights, while maintaining reporting channels staffed by dedicated personnel who conduct thorough investigations. Lumosa maintains strict confidentiality regarding whistleblower identity and case details, and pledges no retaliation against those who report violations in good faith. In 2024, Lumosa recorded no human rights violations.
In addition to actively implementing human-centered management and various welfare measures, the Company has established performance development plans and guidelines for promotion and job rotation in the employee handbook, ensuring that operational performance is appropriately reflected in employee compensation.
To ensure the safety and health of workers and prevent occupational accidents, the Company has established the "Safety and Health Work Guidelines" based on Article 34 of the Occupational Safety and Health Act and Article 41 of the Enforcement Rules of the Occupational Safety and Health Act, which employees are required to follow. In accordance with Article 23 of the Occupational Safety and Health Act, safety and health management personnel have been appointed.
Lumosa firmly believes that corporate responsibility extends far beyond its core business of developing solutions for patients in urgent need of neurological and oncological treatments. We are committed to implementing Environmental, Social, and Governance (ESG) principles and integrating them into our business strategy planning and corporate vision.
Environmental Management
While developing new drugs to address unmet medical needs, we remain vigilant about our environmental footprint. We strive to reduce resource consumption and conserve electricity, promoting material reuse and recycling throughout our operations. Our commitment to environmental management demonstrates our determination to pursue sustainable business practices.
Social Responsibility
Our commitment to social responsibility is embodied in our corporate spirit of "Caring for Life, Selfless Dedication." While we currently do not participate in specific charitable activities, our core mission is to address unmet medical needs—aligning with important social objectives aimed at improving the quality of life for patients globally.
Corporate Governance
Lumosa complies with Taiwan's corporate governance regulations, ensuring transaction transparency and ethical conduct. We strengthen fairness through internal control measures and by promoting prevention of insider trading. We are dedicated to supporting shareholder communication, board oversight, and compliance with legal and regulatory requirements, having appointed a corporate governance officer on May 2023.
To address sustainable development across Environmental, Social, and Governance (ESG) dimensions, our Sustainability Implementation Task Force has established specialized working groups. Responsible departments collect stakeholder concerns regarding environmental protection, occupational safety, supply chain management, labor rights, operational performance, and corporate governance issues, proposing corresponding policies when necessary. To respect stakeholder interests, we have established a dedicated stakeholder section on our company website to appropriately respond to significant sustainability issues of concern.
Lumosa reports ESG implementation results to the Board of Directors at least once annually, deepening board management and participation in the Company's ESG initiatives. Beginning in 2025, we plan to report to the Board on sustainability-related issues, including greenhouse gas inventory, sustainable risk management effectiveness, information security operations, stakeholder communication effectiveness, and corporate governance status.
ESG Outlook
The ESG journey is a process of continuous review and improvement. We are committed to practicing sustainable operations, which not only benefits corporate growth but also creates positive impacts for stakeholders, including investors, business partners, and employees. We sincerely invite you to join this journey and witness how we integrate ESG principles into our corporate culture, demonstrating our firm commitment to caring for life, selfless dedication, and sustainable operations.
Human Rights Policy and Concrete Management Plan
The Company has established human rights policy guidelines based on the Universal Declaration of Human Rights, the UN Guiding Principles on Business and Human Rights, the International Labour Organization standards, and applicable regulations to protect worker rights. Lumosa requires business partners to comply with these standards and local government laws, prohibiting any harm to worker rights and forbidding the use of child labor or worker exploitation.
To ensure compliance, Lumosa follows labor and human rights laws at all operational locations. The company educates new hires and existing employees on human rights protections and worker rights, while maintaining reporting channels staffed by dedicated personnel who conduct thorough investigations. Lumosa maintains strict confidentiality regarding whistleblower identity and case details, and pledges no retaliation against those who report violations in good faith. In 2024, Lumosa recorded no human rights violations.
In addition to actively implementing human-centered management and various welfare measures, the Company has established performance development plans and guidelines for promotion and job rotation in the employee handbook, ensuring that operational performance is appropriately reflected in employee compensation.
To ensure the safety and health of workers and prevent occupational accidents, the Company has established the "Safety and Health Work Guidelines" based on Article 34 of the Occupational Safety and Health Act and Article 41 of the Enforcement Rules of the Occupational Safety and Health Act, which employees are required to follow. In accordance with Article 23 of the Occupational Safety and Health Act, safety and health management personnel have been appointed.
- The Company subsidizes all employees for regular health check-ups annually, ensuring employee health management.
- Fire safety inspections are conducted annually in coordination with the building management committee, along with participation in fire safety drills and education.
- Dry powder fire extinguishers are appropriately placed in all public spaces of the Company, with periodic inspections and maintenance of all fire protection system equipment as required.
- HVAC equipment inspections are carried out in cooperation with the building management committee to maintain indoor air quality and ensure colleagues' physical well-being.
- Access control is enforced in the Company, requiring employees and visitors to swipe cards or undergo verification to enter.
- The Company's laboratory waste liquids and bio-waste are properly contained and temporarily stored.
- Date
- Title
Proper Disposal of Unwanted Medicines
Location: Nangang Software Park II Atrium (No. 3, Park Street, Nangang District, Taipei)
Dispose unwanted medicines properly
Antibiotics or hormones contained in unwanted medicines may pollute rivers and water resources if dumped directed in sink or flushed in the toilet. The pharmacists at the St. Martin De Porres Hospital stated that medicines that do not pollute may be thrown in the trash to be burned. However, drugs with higher toxicity such as anticancer drugs may cause environmental pollution and should be brought back to the hospitals and clinics for proper disposal. The safest way is to bring all the unwanted medicines to the hospitals, clinics or community pharmacies to be processed by the professional staffs. Pharmacists at the Buddhist Dalin Tzu Chi General Hospital indicated that patients may follow the "six steps in reclamation of unwanted medicines" to discard the medicines properly.
